April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback